Clinical Trial Update: ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease [NA]

View source ↗

Summary

An update indicating that InSightec's ExAblate BBB disruption technology is recruiting participants for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: InSightec | Conditions: Alzheimer Disease | NA | Status: RECRUITING